BioLamina

BioLamina is a company specializing in the development and commercialization of recombinant proteins. Its human embryonic tissue contains a high concentration of recombinant laminin, which is a fully defined process reagent. This allows researchers and therapeutic innovators in the field to simulate and precisely control culture conditions when producing stem cell-derived therapies and advanced cell-based disease models.